Banque Cantonale Vaudoise Ironwood Pharmaceuticals Inc Transaction History

Banque Cantonale Vaudoise

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$5.58 - $8.61 $2,365 - $3,650	424 Added 5.9%	7,609 $50,000
Q1 2024 Apr 10, 2024	BUY	$8.32 - $15.45 $5,491 - $10,197	660 Added 10.11%	7,185 $63,000
Q2 2023 Aug 09, 2023	BUY	$10.1 - $11.6 $14,746 - $16,936	1,460 Added 28.83%	6,525 $69,000
Q2 2022 Aug 02, 2022	BUY	$11.05 - $12.72 $55,968 - $64,426	5,065 New	5,065 $58,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.